Clindamycin Phosphate recalls
Clindamycin Phosphate products have been recalled 6 times, most recently on 9 Sep 2026. The recalling company is usually Baxter Healthcare. The most common reason is sterility.
Total recalls6since 2026
Last 12 months6reported
Class I00% of total
Ongoing6latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 83%Class III 1 17%
Why clindamycin phosphate is recalled
Companies
Product types
By year
Ongoing clindamycin phosphate recalls
6 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Phosphate in 9% Sodium Chloride Injection recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 600 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS III | Clindamycin Phosphate USP, 1% (10 mg/mL) recalledClindamycin Phosphate | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
All clindamycin phosphate recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin Phosphate in 9% Sodium Chloride Injection recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 600 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS II | Clindamycin Injection USP in 5% Dextrose, 900 mg recalledClindamycin Phosphate | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS III | Clindamycin Phosphate USP, 1% (10 mg/mL) recalledClindamycin Phosphate | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.